Springhill Medical Center Performs New BPH Procedure

Springhill Medical Center recently became the first hospital south of Birmingham to offer the HYDROS Robotic System, what it calls “the next-generation AI-powered platform for Aquablation therapy to treat men suffering from benign prostatic hyperplasia (BPH)—commonly known as enlarged prostate.” Dr. Willliam Blaylock and his team at Urology Associates in Mobile completed the first procedure on September 30. Aquablation therapy is clinically proven to provide significant, durable BPH symptom relief while preserving sexual function and continence across prostates of all shapes and sizes. Aquablation therapy is unique in its use of real-time, ultrasound-guided, robotic-assisted waterjet technology, allowing surgeons to create a personalized treatment plan that precisely targets which prostate tissue to remove and which to preserve. With this tailored approach, the system accurately removes problematic tissue while safeguarding critical anatomy. HYDROS is designed to improve efficiency, enhance surgeon and staff experience and deliver a more accurate and consistent treatment plan for better clinical outcomes.